"omega-Conotoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.
| Descriptor ID |
D020960
|
| MeSH Number(s) |
D20.888.590.162.720 D23.946.580.590.162.720 D23.946.833.590.162.720
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "omega-Conotoxins".
Below are MeSH descriptors whose meaning is more specific than "omega-Conotoxins".
This graph shows the total number of publications written about "omega-Conotoxins" by people in this website by year, and whether "omega-Conotoxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "omega-Conotoxins" by people in Profiles.
-
Grajny K, Durphy J, Adam O, Azher S, Gupta M, Molho E. Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases. Tremor Other Hyperkinet Mov (N Y). 2020 10 06; 10:37.
-
Wallace MS, Rauck R, Fisher R, Charapata SG, Ellis D, Dissanayake S. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth Analg. 2008 Feb; 106(2):628-37, table of contents.
-
Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage. 2006 May; 31(5):393-406.
-
Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA. 2004 Jan 07; 291(1):63-70.
-
Wermeling D, Drass M, Ellis D, Mayo M, McGuire D, O'Connell D, Hale V, Chao S. Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients. J Clin Pharmacol. 2003 Jun; 43(6):624-36.
-
Fan YP, Puri RN, Rattan S. Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282(3):G461-9.